Abstract:Many local and systemic diseases especially diseases that are leading causes of death globally like chronic obstructive pulmonary disease, atherosclerosis with ischemic heart disease and stroke, cancer and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing coronavirus disease 19 (COVID-19), involve both, (1) oxidative stress with excessive production of reactive oxygen species (ROS) that lower glutathione (GSH) levels, and (2) inflammation. The GSH tripeptide (γ- L-glutamyl-L-cysteinyl-glycine), the most abundant water-soluble non-protein thiol in the cell (1–10 mM) is fundamental for life by (a) sustaining the adequate redox cell signaling needed to maintain physiologic levels of oxidative stress fundamental to control life processes, and (b) limiting excessive oxidative stress that causes cell and tissue damage. GSH activity is facilitated by activation of the Kelch-like ECH-associated protein 1 (Keap1)-Nuclear factor erythroid 2-related factor 2 (Nrf2)-antioxidant response element (ARE) redox regulator pathway, releasing Nrf2 that regulates expression of genes controlling antioxidant, inflammatory and immune system responses. GSH exists in the thiol-reduced (>98% of total GSH) and disulfide-oxidized (GSSG) forms, and the concentrations of GSH and GSSG and their molar ratio are indicators of the functionality of the cell. GSH depletion may play a central role in inflammatory diseases and COVID-19 pathophysiology, host immune response and disease severity and mortality. Therapies enhancing GSH could become a cornerstone to reduce severity and fatal outcomes of inflammatory diseases and COVID-19 and increasing GSH levels may prevent and subdue these diseases. The life value of GSH makes for a paramount research field in biology and medicine and may be key against systemic inflammation and SARS-CoV-2 infection and COVID-19 disease. In this review, we emphasize on (1) GSH depletion as a fundamental risk factor for diseases like chronic obstructive pulmonary disease and atherosclerosis (ischemic heart disease and stroke), (2) importance of oxidative stress and antioxidants in SARS-CoV-2 infection and COVID-19 disease, (3) significance of GSH to counteract persistent damaging inflammation, inflammaging and early (premature) inflammaging associated with cell and tissue damage caused by excessive oxidative stress and lack of adequate antioxidant defenses in younger individuals, and (4) new therapies that include antioxidant defenses restoration.

Glutathione Participation in the Prevention of Cardiovascular Diseases

Glutathione: A Samsonian life-sustaining small molecule that protects against oxidative stress, ageing and damaging inflammation

Disulfide stress and its role in cardiovascular diseases

Glutathione system enhancement for cardiac protection: pharmacological options against oxidative stress and ferroptosis

Glutathione: Role in Oxidative/Nitrosative Stress, Antioxidant Defense, and Treatments

Glutathione: synthesis, mechanism of action, antioxidant and detoxifying role

Role of Dietary Antioxidants in the Preservation of Vascular Function and the Modulation of Health and Disease

Glutathione Metabolism and Its Implications for Health

CVD and Oxidative Stress

Mitochondrial Glutathione in Cellular Redox Homeostasis and Disease Manifestation

Glutathione and glutathione disulfide – their biomedical and pharmaceutical applications

Antioxidant Therapeutic Strategies for Cardiovascular Conditions Associated with Oxidative Stress

Glutathione Protects Brain Endothelial Cells from Hydrogen Peroxide-Induced Oxidative Stress by Increasing Nrf2 Expression

Mitochondrial glutathione, a key survival antioxidant

Impact of glutathione system on coronary heart diseases

Redox Roles of Reactive Oxygen Species in Cardiovascular Diseases

Research Progress of Glutathione in the Prevention and Treatment of Diseases

Ferroptosis in Cardiovascular Disease and Cardiomyopathies: Therapeutic Implications of Glutathione and Iron Chelating Agents

The interplay of glutathione-related processes in antioxidant defense

Glutathione: Pharmacological aspects and implications for clinical use in non-alcoholic fatty liver disease

Oxidative Stress in Cardiovascular Diseases: Still a Therapeutic Target?